There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Maxar Technologies Ltd (NYSE:MAXR) and Yield10 Bioscience Inc (NASDAQ:YTEN) with bullish sentiments.
Maxar Technologies Ltd (MAXR)
Canaccord Genuity analyst Doug Taylor maintained a Buy rating on Maxar Technologies Ltd today and set a price target of $70. The company’s shares opened today at $29.48, close to its 52-week low of $28.77.
Taylor wrote:
“Yesterday, the NGA issued a release confirming the transition of the key EnhancedView contract to the NRO, and alongside it an extension of the current agreement by at least one year at a comparable revenue run-rate. Note that the status of Maxar and DigitalGlobe’s ongoing relationship with the US government is one of a number of concerns plaguing the stock. While this news does not alleviate it altogether, the language used by these agencies supports the ongoing and increasing importance of DigitalGlobe’s data. A longer extension of this agreement ahead of the 2020 expiry of the initial agreement we think would prove a potentially significant catalyst for the stock. We continue to rate Maxar a BUY as we believe that an improving cash flow conversion profile and better general growth outlook in the coming years will warrant a re-inflation of its multiple relative to peers.”
According to TipRanks.com, Taylor is ranked #1352 out of 4872 analysts.
Currently, the analyst consensus on Maxar Technologies Ltd is a Strong Buy with an average price target of $69.33.
See today’s analyst top recommended stocks >>
Yield10 Bioscience Inc (YTEN)
Maxim Group analyst James Jang maintained a Buy rating on Yield10 Bioscience Inc today and set a price target of $7. The company’s shares opened today at $1.62, close to its 52-week low of $1.12.
Jang observed:
“Today, before market open, YTEN announced promising seed yield results for its C3004 gene trait in Camelina in its growth chamber studies.”
According to TipRanks.com, Jang is a 4-star analyst with an average return of 15.9% and a 43.6% success rate. Jang covers the Services sector, focusing on stocks such as Dynagas LNG Partners LP, Nordic American Tanker, and Eagle Bulk Shipping.
Currently, the analyst consensus on Yield10 Bioscience Inc is a Moderate Buy with an average price target of $7.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
